Women's Healthy Ageing Project

Last updated
Women's Healthy Ageing Project
Type of projectMedical research
LocationAustralia
Owner University of Melbourne Faculty of Medicine, Dentistry and Health Sciences & Centre for Neuroscience at the Royal Melbourne Hospital
Key peopleProfessor Cassandra Szoeke, Director & Principal Investigator

Professor Lorraine Dennerstein, Chair Scientific Advisory Board

Contents

Professor Philippe Lehert, Lead Statistician

Professor John Hopper (scientist), Chair Scientific Advisory Board
Established1990

The Women's Healthy Ageing Project (WHAP) is the longest ongoing medical research project examining the health of Australian women. [1] Its landmark studies concern women's heart and brain health, a long-neglected area of specialised research. [1]

It began in 1990 as a longitudinal study of more than 400 Australian-born women and has been recording health changes for 30 years, from midlife to later-life. [2]

The study is run within the Healthy Ageing Program, a research group at the University of Melbourne School of Medicine, in collaboration with the Centre for Medical Research at the Royal Melbourne Hospital. [3]

The Healthy Ageing Program consists of WHAP (1990); the WHAP Generations Study (2021), involving children of the original 1990 WHAP participants; and AgeHAPPY (Healthy Ageing Project Population Youth-Senior) (2018), an online health survey of more than 5,000 participants assessing the impact of lifestyle factors on health and ageing. [4]

History

The program was established in 1990 by leading women's health researcher and psychiatrist Lorraine Dennerstein, who initiated the study to address the lack of attention paid by Australian medical research to diseases women have. [5] [6] WHAP continues to address this issue as it persists in current epidemiological research, heightening awareness with regard to the progression of women through menopause and into ageing. [7]

The project was initiated as a cohort study of more than 2,000 women in 1990. In 1992, the project commenced with the longitudinal followup of over 400 of the original participants. In its first decade, the WHAP was known as the Melbourne Women's Midlife Health Project (MWMHP). [8]

The study's present director and principal investigator is Professor Cassandra Szoeke, a neurologist and researcher in the University of Melbourne School of Medicine. [1] Professor Lorraine Dennerstein and Australian genetic epidemiologist Professor John Hopper serve on the Scientific Advisory Board. [9] [10] Professor Philippe Lehert, a scientist and researcher in mathematical statistics and biostatistics is the Lead Statistician. [11]

WHAP functions as a teaching resource for University of Melbourne post-graduate students who are involved in assessing WHAP women, data-entry, data analysis and contributing to scientific publications. [12]

Research

WHAP aims to identify modifiable midlife risk factors for the development of diseases in later life, improve understanding of the development of age-related chronic diseases, and carry out early disease identification using clinical, biomarker and health risk factors. [8]

With more than 30 years of longitudinal follow up, re-assessing each participant every four years, the study is distinct from other longitudinal datasets in Australia. It maintains a detailed, individualised biobank (including individual DNA and RNA data), imaging database (BMD, XR, MRI, fMRI & Amyloid PET) and physical, in-person measures including biomarkers, clinical assessments, and biometrics. [7] From 1990 to date, the study has built a substantial database of measures such as mood, full neuropsychiatric batteries, dietary intake, physical activity and social connectedness. [7] Together, these individualised datasets allow WHAP to identify patterns and trends across a lifespan and ultimately improve the wellbeing of women in the second half of their lives. [7]

Throughout the lifetime of the project, it has published more than 150 peer-reviewed journal articles in the fields of neurology and cognitive disease, gerontology, psychiatry, women's health, internal medicine and medical imaging. [7] Articles written by WHAP researchers have appeared in leading journals including The Lancet, JAMA, PLOS One, Neurobiology of Aging and Maturitas. [13] [14] [15] [16] [17]

The study's findings have informed the development of international and national policy guidelines on women's health in reports published by Alzheimer's Disease International, the Royal Australian College of General Practitioners, National Academies Press Institute of Medicine, Global Council on Brain Health and Women's Alzheimer's Movement. [18] [19] [20] [21]

The study is governed by a Scientific Advisory Board, including three of the original chief investigators as well as leading clinicians and academic researchers who specialise in a range of areas including cardiovascular health, endocrinology, geriatrics, neurology, obstetrics and gynaecology, psychiatry, public health, epidemiology, rheumatology and women's health. [8]

Collaborators

WHAP researchers have contributed expertise to various international collaborations, including the Global Burden of Disease Study on dementia and the Asia Pacific node of the International Women's Brain Project. [22] [23] [24] Data from the study also contributed to the ReSTAGE Collaboration's Stages of Reproductive Aging Workshop (STRAW) in 2001, facilitating a global standardised staging system for reproductive aging. [25]

Nationally, WHAP collaborates with a number of biomarker programs, ageing studies and brain health initiatives, including Monash University's ASPREE Healthy Ageing Biobank, the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing and the Study of Women's Health Across the Nation. [26]

Media

The World Economic Forum featured WHAP research in an article on the importance of regular exercise in middle age for preventing cognitive decline. [27]

In Dancing with Dementia, a 2015 episode of the Australian TV program SBS Insight, the study's research was used to inform the program's discussion of living with dementia. [28] Its findings on improving modifiable risk factors to prevent Alzheimer's disease were featured in a 2016 episode of the Australian TV program ABC Catalyst. [29] [30]

Funding

The Women's Healthy Ageing Project is primarily funded by the Australian National Health and Medical Research Council (NHMRC) as well as a number of national associations and foundations affiliated with cognitive ageing and women's health. [31]

Related Research Articles

<span class="mw-page-title-main">Dementia</span> Long-term brain disorders causing impaired memory, thinking and behavior

Dementia is the general name for a decline in cognitive abilities that impacts a person's ability to do everyday activities. This typically involves problems with memory, thinking, and behavior. Aside from memory impairment and a disruption in thought patterns, the most common symptoms include emotional problems, difficulties with language, and decreased motivation. The symptoms may be described as occurring in a continuum over several stages. Dementia ultimately has a significant effect on the individual, caregivers, and on social relationships in general. A diagnosis of dementia requires the observation of a change from a person's usual mental functioning and a greater cognitive decline than what is caused by normal aging.

Lifelong learning is the "ongoing, voluntary, and self-motivated" pursuit of knowledge for either personal or professional reasons. It is important for an individual's competitiveness and employability, but also enhances social inclusion, active citizenship, and personal development.

<span class="mw-page-title-main">Diseases of affluence</span> Health conditions thought to be a result of increasing wealth in society

Diseases of affluence, previously called diseases of rich people, is a term sometimes given to selected diseases and other health conditions which are commonly thought to be a result of increasing wealth in a society. Also referred to as the "Western disease" paradigm, these diseases are in contrast to so-called "diseases of poverty", which largely result from and contribute to human impoverishment. These diseases of affluence have vastly increased in prevalence since the end of World War II.

The Nun Study of Aging and Alzheimer's Disease is a continuing longitudinal study, begun in 1986, to examine the onset of Alzheimer's disease. David Snowdon, an Epidemiologist and the founding Nun Study investigator, started the Nun Study at the University of Minnesota, later transferring the study to the University of Kentucky in 1990. In 2008, with Snowdon's retirement, the study returned to the University of Minnesota. The Nun Study was very briefly moved from the University of Minnesota to Northwestern University in 2021 under the directorship of Dr. Margaret Flanagan. The Nun Study is currently housed at the University of Texas Health San Antonio in the Bigg's Institute for Alzheimer's and Neurodegenerative diseases under the continued directorship of Neuropathologist, Dr. Margaret Flanagan.

Alzheimer’s Disease International (ADI) is a not-for-profit, international federation of Alzheimer and dementia associations from around the world. The organization is in official relations with the World Health Organization (WHO). ADI advocates for people living with Alzheimer’s disease and all other types of dementia.

The prevention of dementia involves reducing the number of risk factors for the development of dementia, and is a global health priority needing a global response. Initiatives include the establishment of the International Research Network on Dementia Prevention (IRNDP) which aims to link researchers in this field globally, and the establishment of the Global Dementia Observatory a web-based data knowledge and exchange platform, which will collate and disseminate key dementia data from members states. Although there is no cure for dementia, it is well established that modifiable risk factors influence both the likelihood of developing dementia and the age at which it is developed. Dementia can be prevented by reducing the risk factors for vascular disease such as diabetes, high blood pressure, obesity, smoking, physical inactivity and depression. A study concluded that more than a third of dementia cases are theoretically preventable. Among older adults both an unfavorable lifestyle and high genetic risk are independently associated with higher dementia risk. A favorable lifestyle is associated with a lower dementia risk, regardless of genetic risk. In 2020, a study identified 12 modifiable lifestyle factors, and the early treatment of acquired hearing loss was estimated as the most significant of these factors, potentially preventing up to 9% of dementia cases.

As populations age, caring for people with dementia has become more common. Elderly caregiving may consist of formal care and informal care. Formal care involves the services of community and medical partners, while informal care involves the support of family, friends, and local communities. In most mild-to-medium cases of dementia, the caregiver is a spouse or an adult child. Over the period of time, more professional care in the form of nursing and other supportive care may be required medically, whether at home or in a long-term care facility. There are evidences to show that case management can improve care for individuals with dementia and the experience of their caregivers. Furthermore, case management may reduce overall cost and institutional care in the medium term. Millions of people living in the United States take care of a friend or family member with Alzheimer’s disease or a related dementia.

David John Ames is an Australian psychiatrist and academic. In addition to being Emeritus Professor in the Department of Psychiatry at the University of Melbourne, he is a part-time consultant psychiatrist at a number of hospitals in Melbourne, a professorial fellow with The National Ageing Research Institute and a research fellow at the Howard Florey Institute. Over his career, Ames has written over 56 book chapters, edited 22 books, and has published over 300 articles in peer-reviewed journals. Ames' main research and clinical interests have been the detection and management of Alzheimer's disease (AD), new therapies for AD, and the care of the depressed elderly.

Alzheimer's Disease Neuroimaging Initiative (ADNI) is a multisite study that aims to improve clinical trials for the prevention and treatment of Alzheimer's disease (AD). This cooperative study combines expertise and funding from the private and public sector to study subjects with AD, as well as those who may develop AD and controls with no signs of cognitive impairment. Researchers at 63 sites in the US and Canada track the progression of AD in the human brain with neuroimaging, biochemical, and genetic biological markers. This knowledge helps to find better clinical trials for the prevention and treatment of AD. ADNI has made a global impact, firstly by developing a set of standardized protocols to allow the comparison of results from multiple centers, and secondly by its data-sharing policy which makes available all at the data without embargo to qualified researchers worldwide. To date, over 1000 scientific publications have used ADNI data. A number of other initiatives related to AD and other diseases have been designed and implemented using ADNI as a model. ADNI has been running since 2004 and is currently funded until 2021.

Perminder Sachdev is an Indian neuropsychiatrist based in Australia. He is a professor of neuropsychiatry at the University of New South Wales (UNSW), co-director of the UNSW Centre for Healthy Brain Aging, and clinical director of the Neuropsychiatric Institute at the Prince of Wales Hospital, Sydney. He is considered a trailblazer in the field of neuropsychiatry. Sachdev's research interests include ageing, vascular cognitive disorders such as vascular dementia, and psychiatric disorders.

Although there are many physiological and psychological gender differences in humans, memory, in general, is fairly stable across the sexes. By studying the specific instances in which males and females demonstrate differences in memory, we are able to further understand the brain structures and functions associated with memory.

Lorraine Dennerstein M.B.B.S., Ph.D., D.P.M., M.R.A.N.Z.C.P., F.R.A.N.Z.C.P., HonDMedSc is a leading Australian researcher and practicing psychiatrist specialising in women's mental and sexual health.

The Rush Alzheimer's Disease Center (RADC) is a research center located in Rush University Medical Center. The Rush Alzheimer's Disease Center is one of 29 Alzheimer's centers in the U.S. designated and funded by the National Institute on Aging.

<span class="mw-page-title-main">Miia Kivipelto</span> Finnish neurologist (born 1973)

Miia K. Kivipelto is a Finnish neuroscientist and professor at the University of Eastern Finland and Karolinska Institute in Stockholm. Her research focuses on dementia and Alzheimer's disease.

<span class="mw-page-title-main">Dementia and Alzheimer's disease in Australia</span> Major health issue in Australia

Dementia and Alzheimer's disease in Australia is a major health issue. Alzheimer's disease is the most common type of dementia in Australia. Dementia is an ever-increasing challenge as the population ages and life expectancy increases. As a consequence, there is an expected increase in the number of people with dementia, posing countless challenges to carers and the health and aged care systems. In 2018, an estimated 376,000 people had dementia; this number is expected to increase to 550,000 by 2030 and triple to 900,000 by 2050. The dementia death rate is increasing, resulting in the shift from fourth to second leading cause of death from 2006 to 2015. It is expected to become the leading cause of death over the next number of years. In 2011, it was the fourth leading cause of disease burden and third leading cause of disability burden. This is expected to remain the same until at least 2020.

The National Alzheimer's Project Act is an Act in the United States that was driven by the rapid increasing number of sufferers of Alzheimer's disease. It resulted in a U.S. National Alzheimer's Plan for increased spending on scientific research, care, and public engagement.

Dena Dubal is the David A. Coulter Endowed Chair in Ageing and Neurodegenerative Disease at University of California, San Francisco. Dubal has demonstrated that the hormone Klotho can enhance cognition and protect the brain from neurodegenerative decline.

Started in 2010, The Minnesota Women Healthy Aging Project studies how brain changes with aging vary for different women and what might be the underlying causes of those differences. Initiated by Apostolos Georgopoulos, a Regents Professor of Neuroscience at the University of Minnesota, the premise for the project was inspired by a conversation with his wife, the endocrinologist Lily Georgopoulus, who had observed a small cohort of female patients who were thriving physically and mentally well into their 80s and 90s. Georgopoulos is working with Lisa James, an associate professor of Neuroscience at the University of Minnesota to construct a comprehensive, longitudinal database with information on cognitive abilities and genetic markers that can be used to understand the molecular biology of the aging brain. As of 2019, the study had enrolled over 100 women ranging in age from their 20s to 104 yrs old. Annual checkups are used to track the impact of genetic markers, brain images, diet, exercise and other lifestyle factors on cognitive changes in the women. The data has shown a link between a human leukocyte antigen and brain health with the HLA-DRB1*13:02 allele correlating with less brain damage and with cognitive health over time. This observation provides a molecular mechanism to explain the widely published observation that infections by certain pathogens, such as herpes virus, contribute to loss of brain function and increased incidence of Alzheimer Disease.

<span class="mw-page-title-main">Keenan A. Walker</span> Neuroscience researcher

Keenan A. Walker, Ph.D., directs the Multimodal Imaging of Neurodegenerative Disease unit in the Laboratory of Behavioral Neuroscience at the National Institute on Aging. His research includes studies on Alzheimer's disease.

Cassandra Szoeke is an Australian medical researcher and practicing physician in internal medicine, with a sub-specialisation in neurology.

References

  1. 1 2 3 "'I would watch every episode': charting the 30-year study into Australian women's ageing". The Guardian. 2021-09-25. Retrieved 2022-02-01.
  2. ↑ "What we've learned about women's health over 30 years". ABC Radio National. 2021-08-31. Retrieved 2022-02-01.
  3. ↑ "Cognition- Impact of Ageing and Menopause – AMS" . Retrieved 2022-05-02.
  4. ↑ Cigognini, Brendan (2021-07-26). "AgeHAPPY: Healthy Ageing Project Population Youth-senior". Melbourne Medical School. Retrieved 2022-02-10.
  5. ↑ "The good woman doctor". The Age. Melbourne. 2004-12-05. Retrieved 2022-02-01.
  6. ↑ Priestley, Angela (2021-11-02). "These are the 'loads' impacting women's health". Women's Agenda. Retrieved 2022-02-01.
  7. 1 2 3 4 5 Szoeke, Cassandra; Coulson, Melissa; Campbell, Stephen; Dennerstein, Lorraine (2016-10-04). "Cohort profile: Women's Healthy Ageing Project (WHAP)- a longitudinal prospective study of Australian women since 1990". Women's Midlife Health. 2: 5. doi:10.1186/s40695-016-0018-y. ISSN   2054-2690. PMC   6300017 . PMID   30766701.
  8. 1 2 3 Szoeke, Cassandra E. I.; Robertson, Joanne S.; Rowe, Christopher C.; Yates, Paul; Campbell, Katherine; Masters, Colin L.; Ames, David; Dennerstein, Lorraine; Desmond, Patricia (2013-12-01). "The Women's Healthy Ageing Project: Fertile ground for investigation of healthy participants 'at risk' for dementia". International Review of Psychiatry. 25 (6): 726–737. doi:10.3109/09540261.2013.873394. ISSN   0954-0261. PMID   24423225. S2CID   109484.
  9. ↑ "The good woman doctor". The Age. 2004-12-05. Retrieved 2022-05-02.
  10. ↑ "Director, Professor John Hopper". www.twins.org.au. Retrieved 2022-05-02.
  11. ↑ "Philippe Lehert - Med.E.A." 2020-06-29. Retrieved 2022-05-02.
  12. ↑ Irvine-Nagle, Kali (2022-04-29). "Healthy Ageing Program". Melbourne Medical School. Retrieved 2022-05-24.
  13. ↑ Nichols, Emma; Szoeke, Cassandra E I; Vollset, Stein Emil; Abbasi, Nooshin; Abd-Allah, Foad; Abdela, Jemal; Aichour, Miloud Taki Eddine; Akinyemi, Rufus O; Alahdab, Fares; Asgedom, Solomon W; Awasthi, Ashish (January 2019). "Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016". The Lancet Neurology. 18 (1): 88–106. doi:10.1016/s1474-4422(18)30403-4. ISSN   1474-4422. PMC   6291454 . PMID   30497964.
  14. ↑ Martinkova, Julie; Quevenco, Frances-Catherine; Karcher, Helene; Ferrari, Alberto; Sandset, Else Charlotte; Szoeke, Cassandra; Hort, Jakub; Schmidt, Reinhold; Chadha, Antonella Santuccione; Ferretti, Maria Teresa (2021-09-13). "Proportion of Women and Reporting of Outcomes by Sex in Clinical Trials for Alzheimer Disease: A Systematic Review and Meta-analysis". JAMA Network Open. 4 (9): e2124124. doi: 10.1001/jamanetworkopen.2021.24124 . ISSN   2574-3805. PMID   34515784. S2CID   237491415.
  15. ↑ Szoeke, Cassandra; Dang, Christa; Lehert, Philippe; Hickey, Martha; Morris, Meg E.; Dennerstein, Lorraine; Campbell, Stephen (2017-04-12). "Unhealthy habits persist: The ongoing presence of modifiable risk factors for disease in women". PLOS ONE. 12 (4): e0173603. Bibcode:2017PLoSO..1273603S. doi: 10.1371/journal.pone.0173603 . ISSN   1932-6203. PMC   5389802 . PMID   28403144.
  16. ↑ Ryan, Joanne; Stanczyk, Frank Z.; Dennerstein, Lorraine; Mack, Wendy J.; Clark, Margaret S.; Szoeke, Cassandra; Kildea, Daniel; Henderson, Victor W. (2012-03-01). "Hormone levels and cognitive function in postmenopausal midlife women". Neurobiology of Aging. 33 (3): 617.e11–617.e22. doi:10.1016/j.neurobiolaging.2010.07.014. ISSN   0197-4580. PMID   20888079. S2CID   21693394.
  17. ↑ Burn, Katherine; Szoeke, Cassandra (2016-01-01). "Boomerang families and failure-to-launch: Commentary on adult children living at home". Maturitas. 83: 9–12. doi:10.1016/j.maturitas.2015.09.004. ISSN   0378-5122. PMID   26597141.
  18. ↑ Brooker, Dawn; Peel, Elizabeth; Erol, Rosie (2015-06-01). "Women and Dementia: A global research review".{{cite journal}}: Cite journal requires |journal= (help)
  19. ↑ Lyons, Amanda (8 January 2019). "Study finds modifiable risk factors may have impact on dementia". Royal Australian College of General Practitioners.
  20. ↑ Medicine, Institute of (2015). Blazer, Dan G.; Yaffe, Kristine; Liverman, Catharyn T. (eds.). Cognitive Aging: Progress in Understanding and Opportunities for Action. Washington, DC: The National Academies Press. ISBN   978-0-309-36862-9.
  21. ↑ "It's Time to Act: The Challenges of Alzheimer's and Dementia for Women" (PDF). American Association of Retired Persons. 21 May 2020.
  22. ↑ Annab, Rachid (2019-02-13). "The global burden of dementia has doubled since 1990". Newsroom. Retrieved 2022-02-01.
  23. ↑ "Team - Women's Brain Project". 2021-11-01. Retrieved 2022-02-01.
  24. ↑ "Secrets of Women's Healthy Ageing: Professor Cassandra Szoeke In-Conversation with Professor Susan Hillier". University of South Australia. 2021-10-06.
  25. ↑ Harlow, Siobán D.; Mitchell, Ellen S.; Crawford, Sybil; Nan, Bin; Little, Roderick; Taffe, John (January 2008). "The ReSTAGE Collaboration: Defining Optimal Bleeding Criteria for Onset of Early Menopausal Transition". Fertility and Sterility. 89 (1): 129–140. doi:10.1016/j.fertnstert.2007.02.015. ISSN   0015-0282. PMC   2225986 . PMID   17681300.
  26. ↑ "ASPREE Healthy Ageing Biobank". Monash University. Retrieved 2022-02-01.
  27. ↑ "Is this the key to preventing dementia?". World Economic Forum. 15 June 2016. Retrieved 2022-06-03.
  28. ↑ "Insight S2015 Ep11 - Dancing With Dementia". Guide. 2015-04-28. Retrieved 2022-02-01.
  29. ↑ Alzheimer's - Can we prevent it?, Australian Broadcasting Corporation, 2016-08-23, retrieved 2022-02-01
  30. ↑ Cigognini, Brendan (2016-12-15). "Healthy Ageing Program on ABC Catalyst". Melbourne Medical School. Retrieved 2022-02-01.
  31. ↑ Szoeke, Cassandra; Dang, Christa; Lehert, Philippe; Hickey, Martha; Morris, Meg E.; Dennerstein, Lorraine; Campbell, Stephen (2017-07-07). "Correction: Unhealthy habits persist: The ongoing presence of modifiable risk factors for disease in women". PLOS ONE. 12 (7): e0181287. Bibcode:2017PLoSO..1281287S. doi: 10.1371/journal.pone.0181287 . ISSN   1932-6203. PMC   5501659 . PMID   28686732.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.